Immune Pharmaceuticals
Immune Pharmaceuticals: securities offering (amended)
- Form
- S-1/A
- Filed
- Importance
- Routine
- Accession
- 0001144204-18-065450
- Document
- S-1/A
Not explained yet; the original is on EDGAR.
Securities offering (amended)
Similar companies
Same SIC code (2834) and public float not reported.
